T

Thorne Healthtech Inc
F:F7G

Watchlist Manager
Thorne Healthtech Inc
F:F7G
Watchlist
Price: 11.4 EUR -0.87% Market Closed
Market Cap: €616m

P/OCF

7.6
Current
7%
Cheaper
vs 3-y average of 8.1

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
7.6
=
Market Cap
€599.8m
/
Operating Cash Flow
$93.6m

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
7.6
=
Market Cap
€599.8m
/
Operating Cash Flow
$93.6m

Valuation Scenarios

Thorne Healthtech Inc is trading below its 3-year average

If P/OCF returns to its 3-Year Average (8.1), the stock would be worth €12.23 (7% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+76%
Average Upside
38%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 7.6 €11.4
0%
3-Year Average 8.1 €12.23
+7%
5-Year Average 7.6 €11.43
+0%
Industry Average 12.7 €19.12
+68%
Country Average 13.3 €20.07
+76%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
US
Thorne Healthtech Inc
F:F7G
616m EUR 7.6 12.2
FR
L'Oreal SA
PAR:OR
201.5B EUR 23.3 32.9
UK
Unilever PLC
LSE:ULVR
93.4B GBP 10 11.3
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.6T INR 47.4 37.6
UK
HALEON PLC
LSE:HLN
31.6B GBP 12 19
US
Estee Lauder Companies Inc
NYSE:EL
28.1B USD 16.9 -158.1
DE
Beiersdorf AG
XETRA:BEI
15.8B EUR 20.1 16.8
JP
Kao Corp
TSE:4452
2.7T JPY 13.4 22.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.2T INR 48.9 64.1
CA
Relevium Technologies Inc
XTSX:RLV
12.2B CAD 552.9 -4 624.4
IN
Dabur India Ltd
NSE:DABUR
815.9B INR 42.4 43.3
P/E Multiple
Earnings Growth PEG
US
T
Thorne Healthtech Inc
F:F7G
Average P/E: 28.8
12.2
N/A N/A
FR
L'Oreal SA
PAR:OR
32.9
13%
2.5
UK
Unilever PLC
LSE:ULVR
11.3
-6%
N/A
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
37.6
7%
5.4
UK
HALEON PLC
LSE:HLN
19
11%
1.7
US
Estee Lauder Companies Inc
NYSE:EL
Negative Multiple: -158.1 N/A N/A
DE
Beiersdorf AG
XETRA:BEI
16.8
6%
2.8
JP
Kao Corp
TSE:4452
22.2
10%
2.2
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
64.1
18%
3.6
CA
Relevium Technologies Inc
XTSX:RLV
Negative Multiple: -4 624.4 N/A N/A
IN
Dabur India Ltd
NSE:DABUR
43.3
11%
3.9

Market Distribution

Lower than 76% of companies in the United States of America
Percentile
24rd
Based on 9 488 companies
24rd percentile
7.6
Low
0 — 8.8
Typical Range
8.8 — 20.1
High
20.1 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 8.8
Median 13.3
70th Percentile 20.1
Max 3 188 432.5

Thorne Healthtech Inc
Glance View

Market Cap
616m EUR
Industry
Consumer products

Thorne HealthTech, Inc. is engaged in the provision of a total system for wellness. The company is headquartered in Summerville, South Carolina and currently employs 496 full-time employees. The company went IPO on 2021-09-23. The firm is developing solutions and personalized approaches to health and well-being. The firm's brands, Thorne and Onegevity, provides insights and personalized data, products and services that help individuals take a proactive approach to maintain their health over their lifetime. The firm's Onegevity, is a multi-omics database that uses artificial intelligence (AI) and machine learning to provide insights, with its nutritional supplements. Its Thorne products support the optimization of health and include health tests, education and nutritional supplement products. The firm offers health tests to generate comprehensive, personalized, molecular portraits for its customers. Its portfolio of health tests includes tests focused on sleep, stress, weight management, gut health, heavy metals, and biological age.

F7G Intrinsic Value
37.81 EUR
Undervaluation 70%
Intrinsic Value
Price €11.4
T
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett